COMMD2 and cancer: In the present study, we first performed pancancer analysis of COMMD2 expression using the TIMER and UALCAN databases, and found that COMMD2 was abnormally expressed in the tumor tissues of 13 different cancer types compared with that in the corresponding normal tissues.